Who
Ronald Kirk Huntsman
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Vivos Therapeutics.
In numbers
- Trades disclosed
- 23
- Buys
- 12
- Sells
- 0
- Bought
- $124K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 11 Dec 2020
- Last trade
- 30 Jun 2026
- Last filed
- 18 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Jun 2026filed 18 Sep 2026 | VVOS Vivos TherapeuticsMedical Devices | SEC FORM 4 Code J | $50K85,910 at $0.582 | filing |
| 30 Jun 2026filed 18 Sep 2026 | VVOS Vivos Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code J | $50K85,910 at $0.582 | filing |
| 30 Jun 2026filed 18 Sep 2026 | VVOS Vivos Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code J | $50K85,910 at $0.58 | filing |
| 30 Jun 2026filed 18 Sep 2026 | VVOS Vivos TherapeuticsMedical Devices | SEC FORM 4 Code J | $50K85,910 at $0.58 | filing |
| 26 Nov 2024filed 27 Nov 2024 | VVOS Vivos Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code A | $833K315,421 at $2.64 | filing |
| 20 Jun 2024filed 28 Jun 2024 | VVOS Vivos Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code A | $48K20,000 at $2.38 | filing |
| 20 Jun 2023filed 20 Jun 2023 | VVOS Vivos TherapeuticsMedical Devices | SEC FORM 4 Bought | $7,42014,000 at $0.53 | filing |
| 16 Jun 2023filed 20 Jun 2023 | VVOS Vivos TherapeuticsMedical Devices | SEC FORM 4 Bought | $5,40010,000 at $0.54 | filing |
| 16 Jun 2023filed 20 Jun 2023 | VVOS Vivos TherapeuticsMedical Devices | SEC FORM 4 Bought | $2,6505,000 at $0.53 | filing |
| 15 Jun 2023filed 20 Jun 2023 | VVOS Vivos TherapeuticsMedical Devices | SEC FORM 4 Bought | $1121 at $0.50 | filing |
| 14 Jun 2023filed 15 Jun 2023 | VVOS Vivos TherapeuticsMedical Devices | SEC FORM 4 Bought | $4,90010,000 at $0.49 | filing |
| 23 Dec 2022filed 28 Dec 2022 | VVOS Vivos Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code A | $160K333,334 at $0.48 | filing |
| 23 Dec 2022filed 28 Dec 2022 | VVOS Vivos Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code A | $72K150,000 at $0.48 | filing |
| 23 Dec 2022filed 28 Dec 2022 | VVOS Vivos TherapeuticsMedical Devices | SEC FORM 4 Bought | $10K20,000 at $0.50 | filing |
| 1 Jun 2022filed 3 Jun 2022 | VVOS Vivos TherapeuticsMedical Devices | SEC FORM 4 Bought | $7,3204,000 at $1.83 | filing |
| 31 May 2022filed 3 Jun 2022 | VVOS Vivos TherapeuticsMedical Devices | SEC FORM 4 Bought | $16K8,000 at $2.03 | filing |
| 25 Feb 2022filed 28 Feb 2022 | VVOS Vivos Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code A | $409K125,000 at $3.27 | filing |
| 21 Sep 2021filed 22 Sep 2021 | VVOS Vivos TherapeuticsMedical Devices | SEC FORM 4 Bought | $22K5,000 at $4.31 | filing |
| 17 Aug 2021filed 18 Aug 2021 | VVOS Vivos TherapeuticsMedical Devices | SEC FORM 4 Bought | $15K5,000 at $3.00 | filing |
| 16 Jun 2021filed 14 Feb 2022 | VVOS Vivos Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code A | $705K125,000 at $5.64 | filing |
News
Vivos Therapeutics Strikes $12M Stock Deal For SOD Sciences Stake And Test RightsVVOS · rttnews.com · 15 Oct 2026
0 headlines in the last 90 days name Ronald Kirk Huntsman; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.